Join The REACH Institute for its Primary Pediatric Psychopharmacology (PPP) Mini-Fellowship. This innovative program increases clinicians’ comfort with assessing, diagnosing, and treating pediatric mental health concerns. Participants can earn up to 28.25 AMA PRA Category 1 Credits™ by completing the mini-fellowship components:

• A dynamic three-day, 15-hour interactive course focused on building skills and confidence in diagnosing and treating pediatric behavioral health problems.
• A six-month, case-based distance-learning program. Learners join 12 bi-monthly, 1 hour group conference calls with national primary care and child/adolescent psychiatry experts to learn how to manage pediatric mental health issues encountered in daily practice.

REACH CEO Peter Jensen, MD will lead the PPP mini-fellowship. All participants will receive custom-designed toolkits with guides, assessment instruments, dosing and side effect charts, medication comparison tables, and handouts for patients and parents.

Course Goals
In order to effectively use medications for pediatric behavioral health problems, participants learn to:

1. Correctly identify and differentiate among pediatric behavioral health problems such as childhood depression, ADHD, bipolar disorder, anxiety states (including PTSD), oppositional and conduct disorders, and psychosis.
2. Effectively manage psychopharmacology: selecting medications, initiating and tapering dosages, monitoring improvements, and identifying and minimizing medication side effects.
3. Create and implement a treatment plan by mobilizing existing resources like family members, school personnel, and other professional caregivers.

The course will take place in Los Angeles USC University Center for Excellence in Developmental Disabilities (UCEDD) at Children’s Hospital Los Angeles.

Please register. If you have any questions, please contact Lisa Khan-Kapadia, PPP Program Director, at 1-212-947-7322 ext. 223or email ppp@thereachinstitute.org

The REACH Institute Course (printable version)